Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of CK-1827452 injection in patients with stable heart failure
2006-001871-39Phase 2Completed
- Sponsor
- Cytokinetics
- Start
- Oct 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in heart failure (HF) comparing CK-1827452 dose-escalation with Placebo (2 arms). Primary endpoints: Primary pharmacokinetic endpoint and Primary pharmacodynamic objective. Started Oct 2006; status: completed.
02
Drugs
omecamtiv mecarbil
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on 2006-001871-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001871-39.